Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

PE Firm Carlyle Group Close to Acquiring J&J Diagnostics Unit

Posted in Healthcare Services Investing

Reuters is reporting that PE firm Carlyle Group LP is close to acquiring Johnson & Johnson’s blood-testing unit.

The deal could be finalized within the next two weeks and worth around $4 billion.

Caryle has struck a number of significant healthcare deals over the past several years, including a $3.9 billion takeover (with Hellman & Friedman) of Pharmaceutical Product Development and a $6.3 billion acquisition of nursing home operator ManorCare, according to a New York Times report.

Carlyle Group, based in Washington, D.C., is a global asset management firm specializing in PE. It has more than $185 billion in assets under management across 122 funds and 81 fund of funds vehicles.

 

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.

Agree